Hospital Mortality and Functional Outcomes in Pediatric Neurocritical Care

Cydni N Williams1,2, Carl O Eriksson2, Aileen Kirby2

  • 1Pediatric Critical Care and Neurotrauma Recovery Program and willicyd@ohsu.edu.

Hospital Pediatrics
|November 29, 2019
PubMed

Insights

Pediatric neurocritical care (PNCC) patients face high death rates and new disabilities post-discharge. Outcomes vary significantly by diagnosis, highlighting the need for ongoing multidisciplinary care for survivors.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Pediatrics

Background:

  • Outcomes research in pediatric neurocritical care (PNCC) is limited.
  • Understanding patient outcomes is crucial for improving care and resource allocation.

Purpose of the Study:

  • To evaluate mortality and changes in Functional Status Scale (FSS) from baseline in pediatric neurocritical care (PNCC) patients.
  • To identify variations in outcomes among different PNCC diagnoses.

Main Methods:

  • An observational study of 325 children (0-18 years) admitted to the ICU with a primary neurologic diagnosis.
  • Primary outcomes included death and change in FSS from preadmission baseline to discharge.
  • New disability defined as FSS change ≥1; severe disability as FSS change ≥3.

Main Results:

  • Thirty (9%) patients died. New disability (35%) and severe disability (13%) were common in survivors.
  • Outcomes varied significantly by diagnosis, with infectious/inflammatory and stroke cohorts showing higher disability rates.
  • Disability affected multiple domains, including sensory, motor, and communication; critical care interventions and seizures were associated with new disability.

Conclusions:

  • Pediatric neurocritical care patients experience high rates of mortality and new disability at discharge.
  • Significant variations in outcomes across diagnoses necessitate tailored, multidisciplinary care approaches.
  • This study provides essential data for advancing future research in pediatric neurocritical care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
155
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
214
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177